Mixed antagonistic effects of bilobalide at ρ1 GABAC receptor

被引:9
作者
Huang, SH
Duke, RK [1 ]
Chebib, M
Sasaki, K
Wada, K
Johnston, GAR
机构
[1] Univ Sydney, Dept Pharmacol D06, Fac Med, Adrien Albert Lab Med Chem, Sydney, NSW 2006, Australia
[2] Univ Sydney, Fac Pharm, Sydney, NSW 2006, Australia
[3] Hlth Sci Univ Hokkaido, Dept Hyg Chem, Fac Pharmaceut Sci, Ishikari, Hokkaido 0610293, Japan
基金
英国医学研究理事会;
关键词
picrotoxinin; bilobalide; mixed antagonist; use-dependent action; GABAc receptors; two-electrode voltage clamp;
D O I
10.1016/j.neuroscience.2005.08.071
中图分类号
Q189 [神经科学];
学科分类号
071006 ;
摘要
Bilobalide was found to be a moderately potent antagonist with a weak use-dependent effect at recombinant human rho(1) GABA(C) receptors expressed in Xenopus oocytes using two-electrode voltage clamp methodology. Antagonism of bilobalide at homomeric rho(1) GABA(C) receptors appeared to be mixed. At low concentration, bilobalide (3 mu M) caused a parallel right shift and surmountable GABA maximal response of the GABA dose-response curve characteristic of a competitive antagonist. At high concentrations, bilobalide (10-100 mu M) caused nonparallel right shifts and reduced maximal GABA responses of GABA dose-response curves characteristic of a noncompetitive antagonist. The potency of bilobalide appears to be dependent on the concentrations of GABA and was more potent at lower GABA concentrations. The mechanism of action of bilobalide at p, GABA(C) receptors appears to be similar to that of the chloride channel blocker picrotoxinin. (c) 2005 Published by Elsevier Ltd on behalf of IBRO.
引用
收藏
页码:607 / 617
页数:11
相关论文
共 49 条
[1]  
*AM BOT COUNC, 2000, HERB MED EXP COMM E, P160
[2]   Mutations of the 2′ proline in the M2 domain of the human GABAC ρ1 subunit alter agonist responses [J].
Carland, JE ;
Moore, AM ;
Hanrahan, JR ;
Mewett, KN ;
Duke, RK ;
Johnston, GAR ;
Chebib, M .
NEUROPHARMACOLOGY, 2004, 46 (06) :770-781
[3]   INSECTICIDE ACTION AT THE GABA-GATED CHLORIDE CHANNEL - RECOGNITION, PROGRESS, AND PROSPECTS [J].
CASIDA, JE .
ARCHIVES OF INSECT BIOCHEMISTRY AND PHYSIOLOGY, 1993, 22 (1-2) :13-23
[4]   GABAc receptor antagonists differentiate between human p1 and p2 receptors expressed in Xenopus oocytes [J].
Chebib, M ;
Mewett, KN ;
Johnston, GAR .
EUROPEAN JOURNAL OF PHARMACOLOGY, 1998, 357 (2-3) :227-234
[5]   MIXED EFFECT OF PICROTOXIN ON GABA DOSE CONDUCTANCE RELATION RECORDED FROM LOBSTER MUSCLE [J].
CONSTANTI, A .
NEUROPHARMACOLOGY, 1978, 17 (03) :159-167
[6]  
Davies JA, 2003, PHARMACOPSYCHIATRY, V36, pS84
[7]   BICUCULLINE-INSENSITIVE GABA RECEPTORS - STUDIES ON THE BINDING OF (-)-BACLOFEN TO RAT CEREBELLAR MEMBRANES [J].
DREW, CA ;
JOHNSTON, GAR ;
WEATHERBY, RP .
NEUROSCIENCE LETTERS, 1984, 52 (03) :317-321
[8]   (+)- and (-)-cis-2-Aminomethylcyclopropanecarboxy acids show opposite pharmacology at recombinant ρ1 and ρ2 GABAC receptors [J].
Duke, RK ;
Chebib, M ;
Balcar, VJ ;
Allan, RD ;
Mewett, KN ;
Johnston, GAR .
JOURNAL OF NEUROCHEMISTRY, 2000, 75 (06) :2602-2610
[9]   GABAC receptor ρ subunits are heterogeneously expressed in the human CNS and form homo- and heterooligomers with distinct physical properties [J].
Enz, R ;
Cutting, GR .
EUROPEAN JOURNAL OF NEUROSCIENCE, 1999, 11 (01) :41-50
[10]   Studies on the mechanisms of action of picrotoxin, quercetin and pregnanolone at the GABAρ1 receptor [J].
Goutman, JD ;
Calvo, DJ .
BRITISH JOURNAL OF PHARMACOLOGY, 2004, 141 (04) :717-727